Each outcome: (1) Bleeding (24-hour, short-and medium-term failure to control bleeding), (2) Mortality (short and medium term), and (3) adverse events (major or minor and explained with migration reported).
¼ one time-point defined, 2 ¼ both time points (short and medium term) defined.
Stars: Complications defined as major and minor and timing (including migration of stent)
¼ 2, joined together (major and minor) or partially complete
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Supplementary Table S2 Modified Newcastle-Ottawa Scale for quality assessment-esophageal stent studies Each outcome: (1) bleeding (24-hour, short-and medium-term failure to control bleeding), (2) mortality (short and medium term), and (3) adverse events (major or minor and explained with migration reported)
Stars: Complications defined as major and minor and timing (including migration of stent) ¼ 2, joined together (major and minor) or partially complete ¼1, completely undefined ¼ 0
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